Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Xenolix Technologies (XTCI) 'Ecstasy'(Formerly MGAU)

No earlier versions found for this Subject.

Return to Xenolix Technologies (XTCI) 'Ecstasy'(Formerly MGAU)

The Company is headquartered in Summit, New Jersey and is inventing,
researching and developing new precious metals technologies based upon the application of nanotechnological science it is pioneering. It is creating gold, silver and platinum element analytic and extraction technology based upon this science. The technology is designed to transform refractory (difficult to detect and extract) precious metal-bearing ores into forms of treated ore that respond well to standard analytic and extraction techniques.The Company is attempting to commercialize its nanotechnological intellectual property pertaining to refractory ore. See the Technology Section and Corporate Plan Section on the Xenolix website for details.

Xenolix Technologies, Inc. at 34 Maple St., Summit, NJ 07901 or by calling Shareholder Services at (908) 277-3632 or FAX at (908) 277-2461. Xenolix Technologies information can be found on its website athttp://www.xenolix.com.